|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/56 | (2006.01) |
| A61K 9/00 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/06 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/569 | (2006.01) |
| (11) | Number of the document | 3403654 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18178891.0 |
| Date of filing the European patent application | 2010-09-30 | |
| (97) | Date of publication of the European application | 2018-11-21 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-31 |
| (46) | Date of publication of the claims translation | 2019-09-10 |
| (30) | Number | Date | Country code |
| 24764209 P | 2009-10-01 | US |
| (72) |
PERRETT, Stephen, US
COHEN, Fredric Jay, US
VENKATESH, Gopi M., US
|
| (73) |
Ellodi Pharmaceuticals, L.P.,
1200 Lenox Drive, Suite 100, Lawrenceville, NJ 08648,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Geriamosios kortikosteroido kompozicijos |
| ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS |
| Payment date | Validity (years) | Amount | |
| 2023-08-31 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-09-30 |